Nektar Therapeutics
NKTR
$73.32
-$2.12-2.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 289.04% | 160.07% | -3.71% | 10.52% | -35.15% |
| Total Receivables | 252.04% | 110.04% | 10.57% | -39.28% | -53.40% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.35% | 25.77% | -12.55% | -17.19% | -27.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 535.31% | 91.06% | 749.51% | -79.74% | 79.85% |
| Total Current Assets | 296.32% | 156.20% | 1.90% | -1.79% | -36.80% |
|
|
|||||
| Total Current Assets | 296.32% | 156.20% | 1.90% | -1.79% | -36.80% |
| Net Property, Plant & Equipment | -- | -- | -57.70% | -19.57% | -56.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 231.73% | 108.44% | 21.54% | 14.10% | 16.46% |
| Total Assets | 427.69% | 197.87% | -7.72% | -2.15% | -39.55% |
|
|
|||||
| Total Accounts Payable | 74.29% | -43.78% | -6.83% | 81.45% | 120.56% |
| Total Accrued Expenses | -37.52% | -22.31% | -27.81% | -12.94% | 21.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.16% | 3.15% | 3.16% | 3.16% | 3.16% |
| Total Finance Division Other Current Liabilities | 7.02% | 8.50% | -4.88% | -61.95% | -2.44% |
| Total Other Current Liabilities | 7.02% | 8.50% | -4.88% | -61.95% | -2.44% |
| Total Current Liabilities | -0.57% | -18.64% | -12.81% | -1.84% | 24.54% |
|
|
|||||
| Total Current Liabilities | -0.57% | -18.64% | -12.81% | -1.84% | 24.54% |
| Long-Term Debt | -28.79% | -30.18% | -31.18% | -23.17% | -25.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.67% | -22.76% | -21.09% | -19.62% | -18.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.31% | 25.01% | 19.11% | -27.30% | -30.00% |
| Total Liabilities | -17.15% | -22.86% | -21.61% | -16.53% | -12.10% |
|
|
|||||
| Common Stock & APIC | 29.54% | 19.61% | 5.20% | 4.22% | 0.49% |
| Retained Earnings | -4.26% | -4.33% | -4.56% | -3.35% | -3.43% |
| Treasury Stock & Other | 41.74% | 65.08% | 100.58% | 102.12% | 13.74% |
| Total Common Equity | 3,830.21% | 4,094.32% | 47.90% | 74.06% | -130.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3,830.21% | 4,094.32% | 47.90% | 74.06% | -130.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,830.21% | 4,094.32% | 47.90% | 74.06% | -130.38% |
|
|
|||||